SARS-CoV-2 Specific and Neutralizing Antibodies

SARS-CoV-2 Specific and Neutralizing Antibodies

Research Tools

Information

Sino Biological has developed a large collection of antibodies against different antigens of SARS-CoV-2. These antibodies can be used to detect and/or neutralize the virus in a variety of assays including ELISA, western blot, Immunofluorescent staining, Immunohistochemistry, SPR (Biacore and Octet), psuedovirus infection, and potentially in vivo animal studies.
Link
https://www.sinobiological.com/research/virus/sars-cov-2-antibody
Sino Biological Europe GmbHAs a leading recombinant protein and antibody manufacturer, Sino Biological has the biggest validated recombinant protein bank (6000+), covering most of drug targets and cytokines, with a complete collection of viral proteins and Fc receptors.   We are the first ever company that expressed SARS-CoV-2 proteins and so far still has the most complete COVID19-related product collection with high quality.   We've been cooperating with the most important COVID19 vaccine/therapy/diagnostic assay developers, producing every month tens of grams of different SARS-CoV-2 proteins and antibodies.   Based on its rich experience and expertise on protein and antibody production, Sino Biological also provides the customized services for recombinant production of proteins and antibodies, to our global biotech and biopharma customers.   Sino Biological Europe sits in Frankfurt, Germany, with the local sales/service team and the protein inventory.

Log in

See all the content and easy-to-use features by logging in or registering!